Market Overview:
The global creatinine meter market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of kidney diseases, rising geriatric population, and technological advancements in creatinine meters. Based on type, the global creatinine meter market is segmented into benchtop creatinine meters and handheld creatinine meters. The benchtop Creatinine Meter segment is expected to account for a larger share of the global market than the handheld Creatinine Meter segment during the forecast period. This can be attributed to their wide usage in hospitals and clinics for accurate diagnosis of kidney diseases. Based on application, the global Creatinine Meter Market is divided into four segments: hospitals, clinics, home care setting, and others (laboratories/research institutes). Of these segments, hospitals are expected to account for a larger share of the global market than other segments duringthe forecast period owingto their large patient baseand growing demand for accurate diagnosisof kidney diseases.
Product Definition:
A creatinine meter is a device used to measure the amount of creatinine in the blood. Creatinine is a waste product that is produced when muscles use energy. The level of creatinine in the blood can be used to estimate how well the kidneys are functioning. A high level of creatinine may indicate that the kidneys are not working properly.
Benchtop Creatinine Meter:
The global benchtop creatinine meter market is expected to witness significant growth over the forecast period. The key drivers attributing to the predicted growth include rising incidences of renal disorders and growing awareness regarding early diagnosis amongst patients. Furthermore, increasing demand for point-of-care (POC) diagnostics and technological advancements in this field are also anticipated to boost the market during the forecast period.
Handheld Creatinine Meter:
The handheld creatinine meter is used for measuring the blood or serum creatinine level. Creatinine is an endogenous by-product of muscle metabolism and its measurement in the blood provides information about the kidney function. The normal range for human body is 0.4 - 9 mg/L, while high range levels usually indicate kidney problems, and low levels indicate liver or heart problems.
Application Insights:
The others segment includes the use of creatinine meters in home care settings and other applications. The hospital segment dominated the global market in terms of revenue in 2017, owing to a large number of patients visiting hospitals for various conditions requiring a blood test. This has resulted in an increased demand for these devices, which is expected to continue over the forecast period.
The clinics segment is expected to exhibit lucrative growth over the forecast period due to increasing awareness about preventive healthcare and rising disposable income among consumers globally. These factors are likely drive clinics as well as home care setting Creatinine Meters Market during the study period.
Regional Analysis:
North America dominated the global creatinine meter market in 2017. This can be attributed to favorable reimbursement policies, high healthcare expenditure, and increasing awareness about CKD among patients and physicians. The Asia Pacific is expected to witness the fastest growth over the forecast period owing to rising patient awareness levels coupled with government initiatives for improving public health infrastructure in emerging countries such as India and China. Moreover, a rise in disposable income will boost demand further over the coming years.
Growth Factors:
- Increasing prevalence of kidney diseases and renal failure
- Growing awareness about the benefits of early diagnosis and treatment of kidney diseases
- Technological advancements in creatinine meters that offer enhanced accuracy and precision
- Rising demand for point-of-care diagnostics devices
- Increasing number of clinical studies on creatinine meters
Scope Of The Report
Report Attributes
Report Details
Report Title
Creatinine Meter Market Research Report
By Type
Benchtop Creatinine Meter, Handheld Creatinine Meter
By Application
Hospitals, Clinics, Home Care Setting, Others
By Companies
Abbott, Hitachi, Siemens, Nova, Thermo Fisher Scientific, MedTest Holdings, Diasys Diagnostic Systems, Randox Laboratories, Itron
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
245
Number of Tables & Figures
172
Customization Available
Yes, the report can be customized as per your need.
Global Creatinine Meter Market Report Segments:
The global Creatinine Meter market is segmented on the basis of:
Types
Benchtop Creatinine Meter, Handheld Creatinine Meter
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Home Care Setting, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott
- Hitachi
- Siemens
- Nova
- Thermo Fisher Scientific
- MedTest Holdings
- Diasys Diagnostic Systems
- Randox Laboratories
- Itron
Highlights of The Creatinine Meter Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Benchtop Creatinine Meter
- Handheld Creatinine Meter
- By Application:
- Hospitals
- Clinics
- Home Care Setting
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Creatinine Meter Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A creatinine meter is a device that measures the amount of creatinine in your blood. Creatinine is a waste product that is produced when the body breaks down muscle tissue.
Some of the major companies in the creatinine meter market are Abbott, Hitachi, Siemens, Nova, Thermo Fisher Scientific, MedTest Holdings, Diasys Diagnostic Systems, Randox Laboratories, Itron.
The creatinine meter market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Creatinine Meter Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Creatinine Meter Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Creatinine Meter Market - Supply Chain
4.5. Global Creatinine Meter Market Forecast
4.5.1. Creatinine Meter Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Creatinine Meter Market Size (000 Units) and Y-o-Y Growth
4.5.3. Creatinine Meter Market Absolute $ Opportunity
5. Global Creatinine Meter Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Creatinine Meter Market Size and Volume Forecast by Type
5.3.1. Benchtop Creatinine Meter
5.3.2. Handheld Creatinine Meter
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Creatinine Meter Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Creatinine Meter Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Clinics
6.3.3. Home Care Setting
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Creatinine Meter Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Creatinine Meter Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Creatinine Meter Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Creatinine Meter Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Creatinine Meter Demand Share Forecast, 2019-2026
9. North America Creatinine Meter Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Creatinine Meter Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Creatinine Meter Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Clinics
9.4.3. Home Care Setting
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Creatinine Meter Market Size and Volume Forecast by Type
9.7.1. Benchtop Creatinine Meter
9.7.2. Handheld Creatinine Meter
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Creatinine Meter Demand Share Forecast, 2019-2026
10. Latin America Creatinine Meter Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Creatinine Meter Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Creatinine Meter Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Clinics
10.4.3. Home Care Setting
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Creatinine Meter Market Size and Volume Forecast by Type
10.7.1. Benchtop Creatinine Meter
10.7.2. Handheld Creatinine Meter
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Creatinine Meter Demand Share Forecast, 2019-2026
11. Europe Creatinine Meter Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Creatinine Meter Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Creatinine Meter Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Clinics
11.4.3. Home Care Setting
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Creatinine Meter Market Size and Volume Forecast by Type
11.7.1. Benchtop Creatinine Meter
11.7.2. Handheld Creatinine Meter
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
1.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Creatinine Meter Demand Share, 2019-2026
12. Asia Pacific Creatinine Meter Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Creatinine Meter Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Creatinine Meter Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Clinics
12.4.3. Home Care Setting
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Creatinine Meter Market Size and Volume Forecast by Type
12.7.1. Benchtop Creatinine Meter
12.7.2. Handheld Creatinine Meter
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Creatinine Meter Demand Share, 2019-2026
13. Middle East & Africa Creatinine Meter Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Creatinine Meter Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Creatinine Meter Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Clinics
13.4.3. Home Care Setting
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Creatinine Meter Market Size and Volume Forecast by Type
13.7.1. Benchtop Creatinine Meter
13.7.2. Handheld Creatinine Meter
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Creatinine Meter Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Creatinine Meter Market: Market Share Analysis
14.2. Creatinine Meter Distributors and Customers
14.3. Creatinine Meter Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Abbott
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Hitachi
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Siemens
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Nova
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Thermo Fisher Scientific
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. MedTest Holdings
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Diasys Diagnostic Systems
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Randox Laboratories
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Itron
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
